Stock Research: Evotec

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Evotec

GER:EVT DE0005664809
33
  • Value
    84
  • Growth
    3
  • Safety
    Safety
    50
  • Combined
    31
  • Sentiment
    57
  • 360° View
    360° View
    33
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Evotec SE is a drug discovery and development company. It operates in neuroscience, diabetes, oncology, infectious diseases, and respiratory diseases. Evotec SE operates in Germany. In the last fiscal year, the company had a market cap of $1,491 million, profits of $119 million, and revenue of $825 million, with 4827 employees.

more

ANALYSIS: With an Obermatt 360° View of 33 (better than 33% compared with alternatives), overall professional sentiment and financial characteristics for the stock Evotec are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for Evotec. The consolidated Value Rank has an attractive rank of 84, which means that the share price of Evotec is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 84% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 50. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 57. But the consolidated Growth Rank has a low rank of 3, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 97 of its competitors have better growth. ...read more

more
Index
CDAX
NASDAQ
SDAX
TecDAX
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
84 76 15 6
Growth
3 8 89 63
Safety
Safety
50 44 36 12
Sentiment
57 1 16 49
360° View
360° View
33 10 20 12
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
45 27 78 34
Opinions Change
25 57 21 50
Pro Holdings
n/a 19 14 58
Market Pulse
80 7 29 55
Sentiment
57 1 16 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
84 76 15 6
Growth
3 8 89 63
Safety Safety
50 44 36 12
Combined
31 39 42 8
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
93 80 40 14
Price vs. Earnings (P/E)
86 1 6 1
Price vs. Book (P/B)
87 82 41 45
Dividend Yield
1 1 1 1
Value
84 76 15 6
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
26 65 78 60
Profit Growth
7 10 92 98
Capital Growth
44 4 16 12
Stock Returns
16 10 86 70
Growth
3 8 89 63
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
38 36 40 15
Refinancing
98 77 67 40
Liquidity
15 18 23 23
Safety Safety
50 44 36 12

Similar Stocks

Discover high‑ranked alternatives to Evotec and broaden your portfolio horizons.

Volkswagen VW

GER:VOW
Country: Germany
Industry: Automobile Manufacturers
Size: XX-Large
Full Stock Analysis

Grifols

MCE:GRF
Country: Spain
Industry: Biotechnology
Size: X-Large
Full Stock Analysis

Hornbach Holding

GER:HBH
Country: Germany
Industry: Home Improvement Retail
Size: Large
Full Stock Analysis

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: